Revenue from pharma tests and services, and all other customers in the range of $62 to $64 million; Revenue from population sequencing and enterprise sales in the range of $15 to $16 million; Revenue from clinical tests reimbursed in the range of $3 to $10 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSNL: